Published April 2022 | 10 Pages | 5 Exhibits | Forecasts Through 2026
This report from Life Science Intelligence provides an analysis of the global market for transcatheter devices for the repair and/or replacement of the aortic valve. This thriving medtech market is anticipated to see strong growth, which is largely being driven by the improved access to larger subsets of patients via clinical studies that show the benefit of these technologies in lower risk patients. Epidemiological factors, chiefly the increasing prevalence of heart valve disease, is also increasing the outlook of the TAVI/TAVR devices market.
This market snapshot is intended to provide a high-level overview of the global TAVI/TAVR market, with key insights into:
Abbott
Boston Scientific
Edwards Lifesciences
Foldax
JenaValve Technologies
LivaNova
Medtronic
Pi-Cardia
Venus Medtech
We’re here to help you make smarter decisions and form stronger partnerships through curated events, independent market intelligence products and services, and digital-forward media.
Market Intelligence
Schedule an exploratory call
Request Info17011 Beach Blvd, Suite 500
Huntington Beach, CA 92647
© 2024 Life Science Intelligence, Inc., All Rights Reserved.